Skip to content

Comparative study on the protective effect of MAP solution and CPDA-1 solution on sRBC storage at different time

Comparative study on the protective effect of MAP solution and CPDA-1 solution on sRBC storage at different time

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057741
Enrollment
Unknown
Registered
2022-03-16
Start date
2022-03-09
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:The red blood cells were resuspended in the CPDA-1 fluid
Group 2:The red blood cells are resuspended in the MAP fluid

Sponsors

Affiliated Hospital of Zunyi Medical Universty
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 55 years (no gender limit) undergoing elective minor surgery; 2. Patients with BMI between 18.5 and 23.9, ASA (I-?) and heart function (I-?) levels.

Exclusion criteria

Exclusion criteria: 1. Complicated with hematological diseases including leukemia, abnormal coagulation function and severe anemia; 2. Complicated with endocrine system diseases including hyperthyroidism and Cushing's syndrome; 3. Blood pressure: Systolic blood pressure is above 145mmHg, diastolic pressure is below 60mmHg; 4. Complicated with severe damage of liver and kidney function, diabetes and malignant tumor; 5. Menstruating women and patients with hyperlipidemia; 6. Patients who also participated in other studies.

Design outcomes

Primary

MeasureTime frame
Calcium concentration of intracellular;Intracellular ATP concentration;

Countries

China

Contacts

Public ContactYin Wenjun

Affiliated Hospital of Zunyi Medical University

596887721@qq.com+86 13628521976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026